回复基尔蒂·辛格、斯瓦伦杜·曼达尔、马诺伊·库马尔·达斯、普拉萨特·纳亚克和桑比特·特里帕蒂致编辑的信，内容涉及安德烈亚斯·希斯特、车悦、阿希姆·卢施等人的《精原细胞瘤性睾丸生殖细胞肿瘤临床IIA/B期患者原发性腹膜后淋巴结清扫术的2期单臂试验（PRIMETEST）》。《欧洲泌尿外科杂志》待发表。https://doi.org/10.1016/j.eururo.2022.10.021 。 - Suppr

Suppr

超能文献

Reply to Kirti Singh, Swarnendu Mandal, Manoj Kumar Das, Prasant Nayak, and Sambit Tripathy's Letter to the Editor re: Andreas Hiester, Yue Che, Achim Lusch, et al. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.10.021.

作者信息

Che Yue, Hiester Andreas, Albers Peter

机构信息

Department of Urology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

出版信息

Eur Urol. 2023 Jun;83(6):e157. doi: 10.1016/j.eururo.2023.02.012. Epub 2023 Mar 2.

DOI:10.1016/j.eururo.2023.02.012

PMID:36870796

Abstract

摘要

相似文献

Reply to Kirti Singh, Swarnendu Mandal, Manoj Kumar Das, Prasant Nayak, and Sambit Tripathy's Letter to the Editor re: Andreas Hiester, Yue Che, Achim Lusch, et al. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.10.021.回复基尔蒂·辛格、斯瓦伦杜·曼达尔、马诺伊·库马尔·达斯、普拉萨特·纳亚克和桑比特·特里帕蒂致编辑的信，内容涉及安德烈亚斯·希斯特、车悦、阿希姆·卢施等人的《精原细胞瘤性睾丸生殖细胞肿瘤临床IIA/B期患者原发性腹膜后淋巴结清扫术的2期单臂试验（PRIMETEST）》。《欧洲泌尿外科杂志》待发表。https://doi.org/10.1016/j.eururo.2022.10.021 。

Eur Urol. 2023 Jun;83(6):e157. doi: 10.1016/j.eururo.2023.02.012. Epub 2023 Mar 2.

Re: Andreas Hiester, Yue Che, Achim Lusch, et al. Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.10.021.回复：安德烈亚斯·希斯特、车悦、阿希姆·卢施等。精原细胞瘤性睾丸生殖细胞肿瘤临床IIA/B期患者的原发性腹膜后淋巴结清扫术2期单臂试验（PRIMETEST）。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2022.10.021 。

Eur Urol. 2023 Jun;83(6):e156. doi: 10.1016/j.eururo.2022.12.040. Epub 2023 Mar 9.

Reply to Suman Sahoo, Abhishek Pandy, Swarnendu Mandal, Manoj Kumar Das, and Prasant Nayak's Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003.回复苏曼·萨胡、阿比谢克·潘迪、斯瓦伦杜·曼达尔、马诺伊·库马尔·达斯和普拉萨特·纳亚克致编辑的信，信的内容涉及魏申·谭、亚伦·彭德加斯特、夏洛特·阿克曼等人的《中危非肌层浸润性膀胱癌患者辅助膀胱内热化疗与单纯化疗的对比（HIVEC-II）：一项2期、开放标签、随机对照试验》。《欧洲泌尿外科杂志》待发表。https://doi.org/10.1016/j.eururo.2022.08.003 。

Eur Urol. 2023 Feb;83(2):e48-e49. doi: 10.1016/j.eururo.2022.11.006. Epub 2022 Nov 28.

Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?对阿里雷扎·戈雷菲和胡曼·贾拉达特致编辑的信的回复：关于立花勇、肖恩·Q·克恩、安托万·道格拉斯维等人的文章《病理II期非精原细胞性生殖细胞肿瘤-N1、N2和N3疾病患者的原发性腹膜后淋巴结清扫术：辅助化疗是否必要？》《临床肿瘤学杂志》即将发表。https://doi.org/10.1200/JCO.22.00118：对于所有病理II期非精原细胞瘤生殖细胞肿瘤患者，不进行辅助化疗的腹膜后淋巴结清扫术是否足够？

Eur Urol. 2023 Jan;83(1):e20-e21. doi: 10.1016/j.eururo.2022.09.018. Epub 2022 Oct 1.

Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST).ⅡA/B 期精原细胞瘤患者行原发性腹膜后淋巴结清扫术的单臂Ⅱ期临床试验（PRIMETEST）。

Eur Urol. 2023 Jul;84(1):25-31. doi: 10.1016/j.eururo.2022.10.021. Epub 2022 Nov 10.

Re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?回复：立花勇、肖恩·Q·克恩、安托万·道格拉维等。病理II期非精原细胞瘤性生殖细胞肿瘤N1、N2和N3期患者的原发性腹膜后淋巴结清扫术：辅助化疗是否必要？《临床肿瘤学杂志》。即将发表。https://doi.org/10.1200/JCO.22.00118：对于所有病理II期非精原细胞瘤性生殖细胞肿瘤患者，不进行辅助化疗的腹膜后淋巴结清扫术是否足够？

Eur Urol. 2023 Jan;83(1):e18-e19. doi: 10.1016/j.eururo.2022.08.039. Epub 2022 Oct 1.

Reply to Gregory J. Nason, Michael A.S. Jewett, and Robert J. Hamilton's Letter to the Editor re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607-609: Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.回复格雷戈里·J·纳森、迈克尔·A·S·朱伊特和罗伯特·J·汉密尔顿给编辑的信，主题为：亚当·C·卡拉韦、劳伦斯·H·艾因霍恩、蒂莫西·A·马斯特森、理查德·S·福斯特、克林特·卡里。睾丸癌患者机器人腹膜后淋巴结清扫术相关的不良手术结局。《欧洲泌尿外科杂志》2019年；76卷：607 - 609页：睾丸癌患者机器人腹膜后淋巴结清扫术相关的不良手术结局。

Eur Urol. 2019 Nov;76(5):e141. doi: 10.1016/j.eururo.2019.08.004. Epub 2019 Aug 20.

Reply to Fumihiko Urabe, Takashi Yoshioka, and Takahiro Kimura's Letter to the Editor re: Felix Seelemeyer, David Pfister, Robert Pappesch, Sabine Merkelbach-Bruse, Pia Paffenholz and Axel Heidenreich. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021.回复浦部史彦、吉冈隆、木村孝浩致编辑的信，信的内容涉及：费利克斯·泽勒迈尔、大卫·普菲斯特、罗伯特·帕佩施、萨宾·默克尔巴赫-布鲁斯、皮娅·帕芬霍尔茨和阿克塞尔·海登赖希。评估miRNA - 371a - 3p检测在IIA/B期精原细胞瘤或非精原细胞瘤患者行保留神经的原发性腹膜后淋巴结清扫术中预测最终组织病理学的价值。《欧洲泌尿外科肿瘤学杂志》。即将发表。https://doi.org/10.1016/j.euo.2023.10.021

Eur Urol Oncol. 2024 Apr;7(2):306. doi: 10.1016/j.euo.2024.01.001. Epub 2024 Jan 17.

Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger's Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial. Eur Urol. 2025;87:468-75.对费利克斯·梅尔基奥尔、安德烈亚斯·皮尔彻和伊莎贝尔·海德格尔致编辑信的回复：关于约翰·S·德博诺、孟河、陈石等人。3期IPATential150试验中接受伊帕萨替布和阿比特龙治疗的患者的最终总生存期及与临床结局相关的分子数据。《欧洲泌尿外科杂志》。2025年；87卷：468 - 475页。

Eur Urol. 2025 Jun;87(6):e115-e116. doi: 10.1016/j.eururo.2025.03.020. Epub 2025 Apr 10.

Reply to Hein V. Stroomberg, Klaus Brasso, and Andreas Røder's Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.回复海因·V·斯特鲁姆伯格、克劳斯·布拉索和安德烈亚斯·勒德致编辑的信，内容关于：迈克尔·巴博吉安、罗曼·迪亚曼德、亚历山德罗·乌莱里等人。前列腺癌磁共振成像可见病灶靶向活检的过度分级会导致过度治疗吗？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2024.02.003 。

Eur Urol. 2024 Sep;86(3):e66. doi: 10.1016/j.eururo.2024.05.017. Epub 2024 May 24.

引用本文的文献

Robotic-assisted retroperitoneal lymph node dissection: defining selection parameters-a B-SAFE approach.机器人辅助腹膜后淋巴结清扫术：确定选择参数——一种B-SAFE方法

J Robot Surg. 2025 Mar 11;19(1):111. doi: 10.1007/s11701-025-02273-w.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验